BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26987614)

  • 1. The emerging role of interferon regulatory factor 9 in the antiviral host response and beyond.
    Suprunenko T; Hofer MJ
    Cytokine Growth Factor Rev; 2016 Jun; 29():35-43. PubMed ID: 26987614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The unique role of STAT2 in constitutive and IFN-induced transcription and antiviral responses.
    Blaszczyk K; Nowicka H; Kostyrko K; Antonczyk A; Wesoly J; Bluyssen HA
    Cytokine Growth Factor Rev; 2016 Jun; 29():71-81. PubMed ID: 27053489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type I interferon-regulated gene expression and signaling in murine mixed glial cells lacking signal transducers and activators of transcription 1 or 2 or interferon regulatory factor 9.
    Li W; Hofer MJ; Songkhunawej P; Jung SR; Hancock D; Denyer G; Campbell IL
    J Biol Chem; 2017 Apr; 292(14):5845-5859. PubMed ID: 28213522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mice deficient in STAT1 but not STAT2 or IRF9 develop a lethal CD4+ T-cell-mediated disease following infection with lymphocytic choriomeningitis virus.
    Hofer MJ; Li W; Manders P; Terry R; Lim SL; King NJ; Campbell IL
    J Virol; 2012 Jun; 86(12):6932-46. PubMed ID: 22496215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular expression of IRF9 Stat fusion protein overcomes the defective Jak-Stat signaling and inhibits HCV RNA replication.
    Poat B; Hazari S; Chandra PK; Gunduz F; Alvarez X; Balart LA; Garry RF; Dash S
    Virol J; 2010 Oct; 7():265. PubMed ID: 20939906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinctive Roles for Type I and Type II Interferons and Interferon Regulatory Factors in the Host Cell Defense against Varicella-Zoster Virus.
    Sen N; Sung P; Panda A; Arvin AM
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30089701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT2/IRF9 directs a prolonged ISGF3-like transcriptional response and antiviral activity in the absence of STAT1.
    Blaszczyk K; Olejnik A; Nowicka H; Ozgyin L; Chen YL; Chmielewski S; Kostyrko K; Wesoly J; Balint BL; Lee CK; Bluyssen HA
    Biochem J; 2015 Mar; 466(3):511-24. PubMed ID: 25564224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Combination of IFN β and TNF Induces an Antiviral and Immunoregulatory Program via Non-Canonical Pathways Involving STAT2 and IRF9.
    Mariani MK; Dasmeh P; Fortin A; Caron E; Kalamujic M; Harrison AN; Hotea DI; Kasumba DM; Cervantes-Ortiz SL; Mukawera E; Serohijos AWR; Grandvaux N
    Cells; 2019 Aug; 8(8):. PubMed ID: 31426476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of Tetraodon nigroviridis Mx gene promoter activity by constitutively-active forms of STAT1, STAT2, and IRF9.
    Cheng CH; Chou CM; Chu CY; Chen GD; Lien HW; Hwang PP; Chang MS; Huang CJ
    Fish Shellfish Immunol; 2014 May; 38(1):230-43. PubMed ID: 24680831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noncanonical Effects of IRF9 in Intestinal Inflammation: More than Type I and Type III Interferons.
    Rauch I; Rosebrock F; Hainzl E; Heider S; Majoros A; Wienerroither S; Strobl B; Stockinger S; Kenner L; Müller M; Decker T
    Mol Cell Biol; 2015 Jul; 35(13):2332-43. PubMed ID: 25918247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unphosphorylated ISGF3 drives constitutive expression of interferon-stimulated genes to protect against viral infections.
    Wang W; Yin Y; Xu L; Su J; Huang F; Wang Y; Boor PPC; Chen K; Wang W; Cao W; Zhou X; Liu P; van der Laan LJW; Kwekkeboom J; Peppelenbosch MP; Pan Q
    Sci Signal; 2017 Apr; 10(476):. PubMed ID: 28442624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A hybrid IRF9-STAT2 protein recapitulates interferon-stimulated gene expression and antiviral response.
    Kraus TA; Lau JF; Parisien JP; Horvath CM
    J Biol Chem; 2003 Apr; 278(15):13033-8. PubMed ID: 12574168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different STAT Transcription Complexes Drive Early and Delayed Responses to Type I IFNs.
    Abdul-Sater AA; Majoros A; Plumlee CR; Perry S; Gu AD; Lee C; Shresta S; Decker T; Schindler C
    J Immunol; 2015 Jul; 195(1):210-216. PubMed ID: 26019270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant inflammatory responses to type I interferon in STAT2 or IRF9 deficiency.
    Gothe F; Stremenova Spegarova J; Hatton CF; Griffin H; Sargent T; Cowley SA; James W; Roppelt A; Shcherbina A; Hauck F; Reyburn HT; Duncan CJA; Hambleton S
    J Allergy Clin Immunol; 2022 Oct; 150(4):955-964.e16. PubMed ID: 35182547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9-based Knockout Strategy Elucidates Components Essential for Type 1 Interferon Signaling in Human HeLa Cells.
    Urin V; Shemesh M; Schreiber G
    J Mol Biol; 2019 Aug; 431(17):3324-3338. PubMed ID: 31207241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ISGF3 and STAT2/IRF9 Control Basal and IFN-Induced Transcription through Genome-Wide Binding of Phosphorylated and Unphosphorylated Complexes to Common ISRE-Containing ISGs.
    Nowicka H; Sekrecka A; Blaszczyk K; Kluzek K; Chang CY; Wesoly J; Lee CK; Bluyssen HAR
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kobuvirus VP3 protein restricts the IFN-β-triggered signaling pathway by inhibiting STAT2-IRF9 and STAT2-STAT2 complex formation.
    Peng Q; Lan X; Wang C; Ren Y; Yue N; Wang J; Zhong B; Zhu Q
    Virology; 2017 Jul; 507():161-169. PubMed ID: 28441586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seneca Valley virus 3C
    Song J; Guo Y; Wang D; Quan R; Wang J; Liu J
    J Virol; 2023 Oct; 97(10):e0072723. PubMed ID: 37819133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon Regulatory Factor 9 Structure and Regulation.
    Paul A; Tang TH; Ng SK
    Front Immunol; 2018; 9():1831. PubMed ID: 30147694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In search of a function for human type III interferons: insights from inherited and acquired deficits.
    Zhang Q; Kisand K; Feng Y; Rinchai D; Jouanguy E; Cobat A; Casanova JL; Zhang SY
    Curr Opin Immunol; 2024 Apr; 87():102427. PubMed ID: 38781720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.